Search All Resources
Variant Proportions (CDC)
Type: Website
Audience: Clinical
Data on the variant proportions in the United States.
Date added: 07/24/21
New Variants of the Virus that Causes COVID-19 (CDC)
Type: Website
Audience: Clinical
Information on the new variants of the virus that causes COVID-19.
Date added: 07/24/21
A Closer Look at COVID-19 Diagnostic Testing (FDA)
Type: Website
Audience: Clinical
Consumer overview of COVID-19 testing that has plain language information about both diagnostic and antibody testing.
Date added: 07/24/21
COVID-19 Rapid Point-of-Care Distribution (HHS)
Type: Website
Audience: Clinical
Information regarding HHS distribution of Abbott BinaxNOW COVID-19 test.
Date added: 07/24/21
Overview of Testing for SARS-CoV-2 (CDC)
Type: Website
Audience: Clinical
Guidance on the appropriate use of testing for SARS-CoV-2.
Date added: 07/24/21
SalivaDirect (Yale)
Type: Website
Audience: Clinical
Saliva-based test for COVID-19; eliminates need for nasopharyngeal swabs.
Date added: 07/24/21
COVID-19 Testing and Implications for Public Health Decision Making (USET)
Fact sheet on COVID-19 testing and implications for public health decision making in tribal communities.
Date added: 07/24/21
Current State Laws and Reimbursement Policies (CCHP)
Type: Policies & Procedures
Audience: Clinical
Database for laws and reimbursement policies related to telemedicine for all 50 states.
Date added: 07/24/21
General Telemedicine Toolkit (CMS)
Collection of resources for providers seeking to establish permanent telemedicine programs.
Date added: 07/24/21
DEA Information on Telemedicine (SAMHSA)
Details the fact that during a public health emergency, DEA-registered practitioners may issue prescriptions for controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided several conditions are met.
Date added: 07/24/21
